-capabilities, resourcing and functional service (FSP) solutions. The ClinicalResearchAssociate (CRA) is part of Strategic... research services in more than 40 countries with flexible clinical development and strategic resourcing solutions across key...
Freelance ClinicalResearchAssociate Opportunity in Italy on Medical Device Studies! Are you a Freelance CRA... ClinicalResearchAssociate (CRA) Location: Italy Start Date: Immediate Contract: Initial 12-month contract...
frameworks for clinicalresearch through our PPD clinicalresearch portfolio, our work spans laboratory, digital... resources needed to achieve individual career goals while taking science a step beyond through research, development...
Freelance ClinicalResearchAssociate Opportunity in Italy on Medical Device Studies! Are you a Freelance CRA... ClinicalResearchAssociate (CRA) Location: Italy Start Date: Immediate Contract: Initial 12-month contract...
Freelance ClinicalResearchAssociate Opportunity in Italy on Medical Device Studies! Are you a Freelance CRA...: Freelance ClinicalResearchAssociate (CRA) Location: Italy Start Date: Immediate Contract: Initial 12-month contract...
As a ClinicalResearchAssociate (CRA) you are an essential part of the clinical operations team responsible... for coordinating and overseeing the execution of studies and clinical trial according to the study protocol, ICH-GCP, applicable...
seguenti figure professionali: ClinicalResearchAssociate I (CRA I); ClinicalResearchAssociate II (CRA II...); Senior ClinicalResearchAssociate I (sCRA I). Per tutte le figure, è previsto un inserimento diretto in azienda, a tempo...
seguenti figure professionali: ClinicalResearchAssociate I (CRA I); ClinicalResearchAssociate II (CRA II...); Senior ClinicalResearchAssociate I (sCRA I). Per tutte le figure, è previsto un inserimento diretto in azienda, a tempo...
: ClinicalResearchAssociate I (CRA I); ClinicalResearchAssociate II (CRA II); Senior ClinicalResearchAssociate... mesi di esperienza e formazione specifica sul clinical trial); pregressa esperienza (almeno 1-2 anni) e autonomia nel...
Rafael Nadal says he would like to be remembered as "a kid who followed their dreams" as the tennis great says a poignant farewell to the sport. Continue Reading »
The Indian market faces challenges from rising dollar index and foreign investor outflows. While November shows a 3% decline, analysts predict a recovery in FY25 supported by government spending and consumer demand. Investors should monitor global developments and focus on a diversified portfolio. Continue Reading »
Stock Check: Marico share price dropped 20% from its peak, despite a 20.27% increase in Q2FY25 net profit. Analysts downgraded the stock to 'Accumulate' with a target of ₹678, citing rising costs and slow urban consumption recovery due to high food inflation. Continue Reading »
The NTPC Green Energy IPO, targeting ₹10,000 crore, has seen robust interest, particularly from retail investors. The first day marked a 33% subscription rate, with retail oversubscribing 1.33 times. The offering aims to fund renewable energy projects and reduce existing debts. Continue Reading »
Indian equities faced significant selloff following disappointing September quarter earnings, with mid and small-cap stocks hit hardest. Brokerage firms have lowered earnings estimates, citing reduced government expenditure and slowing urban consumption. Continue Reading »
Stocks to buy or sell: Sagar Doshi of Nuvama Professional Clients Group recommends these three stocks tomorrow - Coromandel International Ltd, Eicher Motors Ltd, and Ipca Laboratories Ltd. Continue Reading »
Expert view: Motilal Oswal's Sneha Poddar expects the Indian stock market to consolidate with sector rotation and volatility. Weak earnings and foreign selling pressure the market. Despite this, long-term growth potential remains, urging investors to gradually build portfolios with quality stocks. Continue Reading »
Multibase India announced an interim dividend of ₹53 per share, the highest in its history, with a record date of November 27. The stock has increased by over 109% in the past year, supported by impressive quarterly financial results. Continue Reading »